These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11423662)
21. Organoarsenicals inhibit bacterial peptidoglycan biosynthesis by targeting the essential enzyme MurA. Garbinski LD; Rosen BP; Yoshinaga M Chemosphere; 2020 Sep; 254():126911. PubMed ID: 32957300 [TBL] [Abstract][Full Text] [Related]
22. Structure of MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) from Vibrio fischeri in complex with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Bensen DC; Rodriguez S; Nix J; Cunningham ML; Tari LW Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Apr; 68(Pt 4):382-5. PubMed ID: 22505403 [TBL] [Abstract][Full Text] [Related]
23. Analysis of six new genes encoding lysis proteins and coat proteins in Escherichia coli group A RNA phages. Nishihara T; Fujisaki S; Nishimura Y; Minami Y; Yubisui T Microbiol Immunol; 2006; 50(1):61-6. PubMed ID: 16428875 [TBL] [Abstract][Full Text] [Related]
24. Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. Rausch S; Hänchen A; Denisiuk A; Löhken M; Schneider T; Süssmuth RD Chembiochem; 2011 May; 12(8):1171-3. PubMed ID: 21538763 [No Abstract] [Full Text] [Related]
25. A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). Eschenburg S; Priestman MA; Abdul-Latif FA; Delachaume C; Fassy F; Schönbrunn E J Biol Chem; 2005 Apr; 280(14):14070-5. PubMed ID: 15701635 [TBL] [Abstract][Full Text] [Related]
26. Molecular modeling and bioinformatical analysis of the antibacterial target enzyme MurA from a drug design perspective. Klein CD; Bachelier A J Comput Aided Mol Des; 2006; 20(10-11):621-8. PubMed ID: 17124631 [TBL] [Abstract][Full Text] [Related]
27. Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli. Kumar S; Parvathi A; Hernandez RL; Cadle KM; Varela MF Arch Microbiol; 2009 May; 191(5):425-9. PubMed ID: 19277606 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA. Hrast M; Rožman K; Jukič M; Patin D; Gobec S; Sova M Bioorg Med Chem Lett; 2017 Aug; 27(15):3529-3533. PubMed ID: 28579123 [TBL] [Abstract][Full Text] [Related]
29. Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors. Barbosa MD; Yang G; Fang J; Kurilla MG; Pompliano DL Antimicrob Agents Chemother; 2002 Apr; 46(4):943-6. PubMed ID: 11897573 [TBL] [Abstract][Full Text] [Related]
30. MurAA, catalysing the first committed step in peptidoglycan biosynthesis, is a target of Clp-dependent proteolysis in Bacillus subtilis. Kock H; Gerth U; Hecker M Mol Microbiol; 2004 Feb; 51(4):1087-102. PubMed ID: 14763982 [TBL] [Abstract][Full Text] [Related]
31. Avenaciolides: potential MurA-targeted inhibitors against peptidoglycan biosynthesis in methicillin-resistant Staphylococcus aureus (MRSA). Chang CM; Chern J; Chen MY; Huang KF; Chen CH; Yang YL; Wu SH J Am Chem Soc; 2015 Jan; 137(1):267-75. PubMed ID: 25521652 [TBL] [Abstract][Full Text] [Related]
32. A cryptic lysis gene near the start of the Qbeta replicase gene in the +1 frame. Nishihara T; Morisawa H; Ohta N; Atkins JF; Nishimura Y Genes Cells; 2004 Oct; 9(10):877-89. PubMed ID: 15461660 [TBL] [Abstract][Full Text] [Related]
33. The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection. Sapkota M; Marreddy RKR; Wu X; Kumar M; Hurdle JG Anaerobe; 2020 Feb; 61():102129. PubMed ID: 31760080 [TBL] [Abstract][Full Text] [Related]
34. MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli. Brown ED; Vivas EI; Walsh CT; Kolter R J Bacteriol; 1995 Jul; 177(14):4194-7. PubMed ID: 7608103 [TBL] [Abstract][Full Text] [Related]
36. Lysis of Escherichia coli after infection with phiX174 depends on the regulation of the cellular autolytic system. Lubitz W; Halfmann G; Plapp R J Gen Microbiol; 1984 May; 130(5):1079-87. PubMed ID: 6236279 [TBL] [Abstract][Full Text] [Related]
37. Characterization of mycobacterial UDP-N-acetylglucosamine enolpyruvyle transferase (MurA). Xu L; Wu D; Liu L; Zheng Q; Song Y; Ye L; Sha S; Kang J; Xin Y; Ma Y Res Microbiol; 2014; 165(2):91-101. PubMed ID: 24463011 [TBL] [Abstract][Full Text] [Related]
38. Role of UDP-N-acetylmuramic acid in the regulation of MurA activity revealed by molecular dynamics simulations. de Oliveira MVD; da Costa KS; Silva JRA; Lameira J; Lima AH Protein Sci; 2024 Apr; 33(4):e4969. PubMed ID: 38532715 [TBL] [Abstract][Full Text] [Related]
39. Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release. Eschenburg S; Priestman M; Schönbrunn E J Biol Chem; 2005 Feb; 280(5):3757-63. PubMed ID: 15531591 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Kim DH; Lees WJ; Kempsell KE; Lane WS; Duncan K; Walsh CT Biochemistry; 1996 Apr; 35(15):4923-8. PubMed ID: 8664284 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]